Ratings by Truist Securities (Greg Renza)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/13/2026 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2026 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2026 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2026 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 10/7/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2026 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2026 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2026 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2026 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 7/7/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2026 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2026 | Nuvalent | NUVL | Downgrade | Hold (Buy) |
88.49 (123.96) |
40.08% | Details | |
| 6/9/2026 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2026 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2026 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2026 | Bicycle Therapeutics | BCYC | Maintain | Hold (N/A) |
|
Details | ||
| 5/1/2026 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 4/30/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2026 | Ascentage Pharma Group | AAPG | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 4/1/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2026 | Bicycle Therapeutics | BCYC | Maintain | Hold (N/A) |
|
Details | ||
| 3/17/2026 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | Fulcrum Therapeutics | FULC | Maintain | (N/A) |
|
Details | ||
| 2/24/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2025 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2025 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2025 | Perspective Therapeutics Inc | CATX | New Coverage | Buy (N/A) |
2.09 (1.61) |
-22.97% | Details | |
| 11/24/2025 | Gilead Sciences | GILD | New Coverage | Buy (N/A) |
126.64 (156.04) |
23.22% | Details | |
| 11/24/2025 | Nurix | NRIX | New Coverage | Buy (N/A) |
16.76 (25.34) |
51.19% | Details | |
| 11/24/2025 | Regeneron Pharma | REGN | New Coverage | Buy (N/A) |
755.90 (805.02) |
6.5% | Details | |
| 11/24/2025 | Amgen | AMGN | New Coverage | Hold (N/A) |
337.54 (439.26) |
30.14% | Details | |
| 11/24/2025 | Ascentage Pharma Group | AAPG | New Coverage | Buy (N/A) |
30.64 (15.44) |
-49.61% | Details | |
| 11/24/2025 | Nuvalent | NUVL | New Coverage | Buy (N/A) |
105.88 (88.49) |
-16.42% | Details | |
| 11/24/2025 | CG Oncology | CGON | New Coverage | Buy (N/A) |
42.44 (61.71) |
45.41% | Details | |
| 11/24/2025 | MannKind | MNKD | New Coverage | Buy (N/A) |
5.03 (3.19) |
-36.58% | Details | |
| 11/24/2025 | Nuvation Bio Inc | NUVB | New Coverage | Buy (N/A) |
6.99 (4.57) |
-34.62% | Details | |
| 11/24/2025 | Viridian Therapeutic | VRDN | New Coverage | Buy (N/A) |
30.34 (22.37) |
-26.27% | Details | |
| 11/24/2025 | Fulcrum Therapeutics | FULC | New Coverage | Buy (N/A) |
11.29 (6.92) |
-38.71% | Details | |
| 11/24/2025 | Bicycle Therapeutics | BCYC | New Coverage | Hold (N/A) |
6.32 (3.55) |
-43.83% | Details | |
| 11/24/2025 | Ideaya Biosciences | IDYA | New Coverage | Buy (N/A) |
33.99 (34.71) |
2.12% | Details | |
| 11/24/2025 | Abivax | ABVX | New Coverage | Buy (N/A) |
119.12 (88.01) |
-26.12% | Details | |
| 11/24/2025 | Agios Pharma | AGIO | New Coverage | Buy (N/A) |
25.24 (37.00) |
46.59% | Details |
